BCYC
Bicycle Therapeutics plc
NASDAQ · Healthcare · Biotechnology · GB
$4.30
+1.42%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.97x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.07x
- Net debt / EBITDA
- 2.71x
Liquidity & coverage
- Current ratio
- 12.08x
- Quick ratio
- 12.08x
- Cash ratio
- 10.71x
- Interest coverage
- —
- EBITDA / interest
- -949.22x
- Working capital
- $527.6M
Cash & dividend
- FCF / debt
- -15.03x
- Cash flow / debt
- -15.04x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026